Filtered By:
Education: Study
Management: Economics

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 226 results found since Jan 2013.

Centralisation of acute stroke services in London: Impact evaluation using two treatment groups
This study evaluates the impact of centralising London's stroke care on 7 process and outcome indicators using a difference‐in‐difference analysis with two treatment groups, Hyper Acute and discontinued London Trusts, and data on all stroke patients recorded in the hospital episode statistics database from April 2006 to April 2014. The policy resulted in improved thrombolysis treatment and lower rates of pneumonia in acute units. However, 6 indicators worsened in the Trusts that were meant to discontinue services, including deaths within 7 and 30 days, readmissions, brain scan rates, and thrombolysis treatment. The re...
Source: Health Economics - December 28, 2017 Category: Health Management Authors: Rocco Friebel, Katharina Hauck, Paul Aylin Tags: RESEARCH ARTICLE Source Type: research

The weekend effect in stroke mortality: evidence from Austrian acute care hospitals
AbstractMany studies provide evidence for the so-called weekend effect by demonstrating that patients admitted to hospital during weekends show less favourable outcomes such as increased mortality, compared with similar patients admitted during weekdays. The underlying causes for this phenomenon are still discussed controversially. We analysed factors influencing weekend effects in inpatient care for acute stroke in Austria. The study analysed secondary datasets from all 130 public acute care hospitals in Austria between 2010 and 2014 (Austrian DRG Data). The study cohort included 86,399 patient cases admitted with acute i...
Source: International Journal of Health Care Finance and Economics - November 3, 2021 Category: Health Management Source Type: research

Cost-effectiveness of Stent-retriever Thrombectomy in combination with IV t-PA Compared with IV t-PA Alone for Acute Ischemic Stroke in the UK.
CONCLUSIONS: Combined stent-retriever neurothrombectomy and IV t-PA is a cost-effective treatment for acute ischemic stroke compared with IV t-PA alone. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov. Identifier: NCT01657461 * Solitaire Revascularization Device is a registered trademark of Medtronic, Irvine, CA, USA. PMID: 27046347 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - April 6, 2016 Category: Health Management Tags: J Med Econ Source Type: research

Real-world comparison of all-cause hospitalizations, hospitalizations due to stroke and major bleeding, and costs for nonvalvular atrial fibrillation patients prescribed oral anticoagulants in a US health plan.
CONCLUSIONS: This study demonstrated a significantly higher risk of hospitalization (all-cause, stroke/SE, and major bleeding) associated with warfarin, a significantly higher risk of major bleeding hospitalization associated with dabigatran or rivaroxaban, and a significantly higher risk of all-cause hospitalization associated with rivaroxaban compared to apixaban. Lower major bleeding-related costs were observed for apixaban patients compared to warfarin and rivaroxaban patients. PMID: 29047304 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - October 20, 2017 Category: Health Management Tags: J Med Econ Source Type: research

Health Economic Evaluations of Digital Health Interventions for Secondary Prevention in Stroke Patients: A Systematic Review
Background: In the first 5 years after their stroke, about a quarter of patients will suffer from a recurrent stroke. Digital health interventions facilitating interactions between a caregiver and a patient from a distance are a promising approach to improve patient adherence to lifestyle changes proposed by secondary prevention guidelines. Many of these interventions are not implemented in daily practice, even though efficacy has been shown. One of the reasons can be the lack of clear economic incentives for implementation. We propose to map all health economic evidence regarding digital health interventions for secondary...
Source: Cerebrovascular Diseases Extra - January 13, 2019 Category: Neurology Source Type: research

Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients
ConclusionsThe use of a blood biomarker test to guide pre-hospital thrombolysis is cost-effective compared with standard hospital care in patients with ischemic stroke.
Source: The European Journal of Health Economics - July 27, 2022 Category: Health Management Source Type: research

The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke
Conclusions We found lower patient costs and higher QoL than expected. This may be explained by the good state of health of our study population and by change in the Dutch healthcare system, which has led to considerable shorter hospitalisation poststroke. Future research must question the use of the EQ-5D-3L in a similar population due to ceiling effects. Trial registration number NTR3051.
Source: BMJ Open - November 27, 2015 Category: Journals (General) Authors: van Eeden, M., van Heugten, C., van Mastrigt, G. A. P. G., van Mierlo, M., Visser-Meily, J. M. A., Evers, S. M. A. A. Tags: Open access, Health economics Research Source Type: research

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
Conclusion: In addition to the substantial costs of the initial hospitalization of an AIS, these costs double within the year following this event. Given the high cost associated with AIS, new interventions reducing either the acute or longer-term burden of AIS are needed. Keywords: acute ischemic stroke, health-care resource utilization, health-care costs, readmissions
Source: ClinicoEconomics and Outcomes Research - February 22, 2016 Category: Health Management Tags: ClinicoEconomics and Outcomes Research Source Type: research

Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation.
CONCLUSIONS: The NNT calculation, when approached and interpreted properly, is a practical measure of the effectiveness of a treatment. The calculation based on HRs showed that NOACs are safe and effective alternatives to VKAs in real life. PMID: 30969801 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - April 12, 2019 Category: Health Management Tags: J Med Econ Source Type: research

Stroke recurrence among stroke patients referred for driving assessment and rehabilitation: a cohort study - Venketasubramanian N, Chan ML.
This study was performed to study the impact of various vascular risk factors on st...
Source: SafetyLit - March 1, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide
CONCLUSIONS: The requirement for calibration to replicate the outcomes observed in SUSTAIN 6 suggests that the reductions in risk of cardiovascular complications observed with once-weekly semaglutide cannot be solely explained by differences in conventional risk factors. Accurate estimation of the risk of diabetes-related complications using methods such as calibration is important to ensure accurate cost-effectiveness analyses are conducted.PMID:37525970 | DOI:10.1080/13696998.2023.2240957
Source: Journal of Medical Economics - August 1, 2023 Category: Health Management Authors: Sasha Berry Barrie Chubb Annabel Acs Edel Falla Akanksha Verma Samuel Jp Malkin Barnaby Hunt Andrew J Palmer Source Type: research